<乌鸦传媒>Red Cell Distribution Width Strongly Predicts Hip Fracture Simple way to identify at-risk patients Sep 24, 2019
<乌鸦传媒>Dapagliflozin: More Good News in HF SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use Sep 19, 2019
<乌鸦传媒>Could Mom's Anemia Hurt Baby's Brain? Association study suggests an increased risk, though still quite small Sep 18, 2019
<乌鸦传媒>Translational Research: Diet Affects the Heart in Multiple Ways Inflammation, circadian rhythm, and beyond Sep 16, 2019
<乌鸦传媒>Shared Decision-Making: Cardiologists Moving Through the Stages of Grief Rules from CMS for ICDs, LAA closure feels arbitrary, some say Sep 16, 2019
<乌鸦传媒>Patiromer Helps CKD Patients Stay on Spironolactone Now the question is: Can outcomes be improved? Sep 15, 2019
<乌鸦传媒>Study: LVAD Surgical Technique Can be Further Refined Left ventricular assist device outflow cannula angulation, anastomosis size may be important Sep 15, 2019
<乌鸦传媒>Debate: Is LVEF Really that Important in Heart Failure? Benefit of identifying preserved, reduced, mid-range, supranormal EF under question Sep 14, 2019
<乌鸦传媒>Meta-Analysis: Renal Events 'Rare' After Denervation for HTN Stenosis, stenting happen within the year when they do occur Sep 06, 2019
<乌鸦传媒>Post-MI Survival Better With ICD for Some, Troubled Trial Suggests Potential benefit in STEMI survivors with severe LV dysfunction, other risk factors soon after PCI Sep 04, 2019
<乌鸦传媒>MITRA-FR Inches in Line With COAPT at 2 Years Despite Contradictory Findings More evidence that the two trials are more concordant than previously thought Sep 02, 2019
<乌鸦传媒>Bariatric Surgery Tied to Better Cardiometabolic Health Down the Road Improvements beyond risk factor reduction in patients with T2D and obesity Sep 02, 2019
<乌鸦传媒>Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetes DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019 video
<乌鸦传媒>Extended DAPT with Brilinta: No Benefit for Stable CAD in T2D Substudy in those with prior PCI might identify group where bleeding tradeoff is worthwhile Sep 01, 2019
<乌鸦传媒>Entresto Signals Expansion Into 'Gray Zone' of HFpEF PARAGON-HF may have missed overall, but HF docs see reason for hope Sep 01, 2019
<乌鸦传媒>Osteoporosis Drug Wins; Tramadol and Blood Sugar News and commentary from the endocrinology world Aug 30, 2019
<乌鸦传媒>STICH: CABG Survival Benefit Doesn't Hinge on Myocardial Viability Is viability testing now unnecessary for CAD patients with low LVEF? Aug 21, 2019
<乌鸦传媒>GLP-1 RA Benefits Extend Beyond MACE Reduction Meta-analysis pooled data on all major outcomes trials for agent class Aug 16, 2019
<乌鸦传媒>There Is Such Thing as a Too-High LVEF Study suggests sweet spot and proposes fourth left ejection phenotype Aug 07, 2019
<乌鸦传媒>Omron Evolv One-Piece BP Monitor: Accurate, Quick, Connected The Skeptical Cardiologist has a new favorite Jul 27, 2019
<乌鸦传媒>ATTR Cardiomyopathy: 'Red Flags' for Screening Consensus group highlights eight things to look for Jul 11, 2019
<乌鸦传媒>Entresto Out-of-Pocket Costs Out of Control? Study highlights one reason for "sluggish" uptake Jul 10, 2019
<乌鸦传媒>Carpal Tunnel Syndrome: 'Red Flag' for Subsequent ATTR, Heart Failure Goal is to catch cardiac amyloidosis early, clinicians say Jul 01, 2019
<乌鸦传媒>Dialysis Takes Heavy Toll on Elderly Loss of independence and increased caregiver burden common, study found Jun 27, 2019
<乌鸦传媒>Another Tricuspid Repair System Shows Promise Device is designed for individual leaflet capture Jun 17, 2019
<乌鸦传媒>Low-Risk TAVR: Listen to the Echo Parameters Smaller annuli may benefit more from transcatheter valves Jun 17, 2019
<乌鸦传媒>Makeover for TAVR Valves: Lower Profiles, Better Sealing Design features suggest several possibilities for improvement over current devices Jun 14, 2019
<乌鸦传媒>TAVR in Low-Risk Patients: Meta-Analyses Have Their Say Improved outcomes overall, but not without downsides Jun 14, 2019
<乌鸦传媒>Pricey Brain Protection Devices of Questionable Value in TAVR Can TAVR programs survive using filters, deflectors in every case? Jun 13, 2019
<乌鸦传媒>TAVR Operators Urged to Tread Carefully on BASILICA TVT Registry to start collecting data on technique's use Jun 12, 2019
<乌鸦传媒>No Added CV Risk for Oral Semaglutide in T2D Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
<乌鸦传媒>Urine Marker Predicts Kidney Benefit With Trulicity Secondary AWARD-7 analysis finds subgroup getting the most renal protection Jun 11, 2019
<乌鸦传媒>Dapagliflozin Boosts Renal Function in T2D Secondary outcomes build on previously reported cardiovascular benefit from SGLT2 inhibitors Jun 10, 2019
<乌鸦传媒>Another GLP-1 Agent Cuts Heart Risk in T2D Dulaglutide added to the growing list of diabetes treatments to show added benefit Jun 10, 2019
<乌鸦传媒>Novel Anti-CD3 Antibody Delays Progression to T1D Single course of teplizumab slowed march to clinical type 1 diabetes in high-risk people Jun 09, 2019
<乌鸦传媒>Expert Panel Defines CGM Time-in-Range Targets Seventy percent of readings should stay between 70-180 mg/dL, according to recommendations Jun 09, 2019
<乌鸦传媒>Vitamin D Flops for Diabetes Prevention Highly anticipated trial finds no significant difference compared to placebo after nearly three years follow-up Jun 07, 2019
<乌鸦传媒>T2D, Cholesterol, and Neuropathy: What's the Link? Lower LDL cholesterol might be a risk factor for nerve damage in type 2 diabetes May 31, 2019
<乌鸦传媒>Slicer Seen Boosting Leaflet Mobility in Aortic Stenosis Study shows feasibility of novel treatment for calcified aortic stenosis May 24, 2019
